Proteostasis Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Proteostasis Therapeutics's estimated annual revenue is currently $750M per year.
- Proteostasis Therapeutics's estimated revenue per employee is $83,333,333
- Proteostasis Therapeutics's total funding is $105M.
Employee Data
- Proteostasis Therapeutics has 9 Employees.
- Proteostasis Therapeutics grew their employee count by 0% last year.
Proteostasis Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Product Development | Reveal Email/Phone |
2 | VP, Human Resources | Reveal Email/Phone |
3 | SVP, Legal Affairs | Reveal Email/Phone |
4 | Senior Director, Biology | Reveal Email/Phone |
5 | Director, Scientific Communications and Community Engagement | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Cell Culture Specialist. Biosafety Officer. General Lab Management. | Reveal Email/Phone |
9 | Research Associate | Reveal Email/Phone |
10 | President & CEO | Reveal Email/Phone |
Proteostasis Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Proteostasis Therapeutics?
Proteostasis Therapeutics, Inc. is the first company dedicated to the discovery of new therapeutics based upon understanding the body’s natural Proteostasis Network. Advances in our ability to characterize and pharmacologically control the Proteostasis Network create new opportunities for ameliorating diseases in a wide number of therapeutic areas. Regulation of the Proteostasis Network is a new approach to drug discovery that will provide the kind of foundational understanding that we have witnessed with other breakthrough treatment paradigms, such as with kinases and G-protein coupled receptors.
keywords:N/A
$105M
Total Funding
9
Number of Employees
$750M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Proteostasis Therapeutics News
Proteostasis Therapeutics; PTC Therapeutics; United Medical; Venus Remedies. Customization of the Report: This report can be customized to meet...
Previously, he was the Corporate Controller for Proteostasis Therapeutics and the Vice President and Chief Accounting Officer for Northern...
Her career in biopharma spans more than 20 years, including clinical operations leadership roles with Proteostasis Therapeutics,...
BOSTON, Aug. 24, 2020 /PRNewswire/ -- Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) today announced that the companies have entered into a definitive merger agreement. The combined company, operating under the name Yumanity Therapeutics, Inc., will leverage a common sci ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.2M | 9 | -47% | $72.3M |
#2 | $0.1M | 9 | 0% | $17.1M |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |